VANCOUVER, BC -- (MARKET WIRE) -- September 13, 2006 -- Upstream Biosciences Inc. (OTCBB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, is pleased to announce that, on September 12, 2006, it filed a provisional patent application with the U.S. Patent and Trademark Office for certain ovarian cancer biomarkers that could be useful for determining whether patients have a genetic risk of developing ovarian cancer.
